Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsRigosertib monotherapy or in combination therapy with immune checkpoint blockade were investigated using immunocompetent mouse models of BRAFwt and BRAFmut melanoma and analyzed in reference to patient data.
[Molecular Cancer]
7753456 {7753456:TKU98BGT} apa 50 1 163377 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-5781b05b6841ee5824561903569c38e2%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22TKU98BGT%22%2C%22library%22%3A%7B%22id%22%3A7753456%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yan%20et%20al.%22%2C%22parsedDate%22%3A%222021-06-06%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EYan%2C%20C.%2C%20Saleh%2C%20N.%2C%20Yang%2C%20J.%2C%20Nebhan%2C%20C.%20A.%2C%20Vilgelm%2C%20A.%20E.%2C%20Reddy%2C%20E.%20P.%2C%20Roland%2C%20J.%20T.%2C%20Johnson%2C%20D.%20B.%2C%20Chen%2C%20S.-C.%2C%20Shattuck-Brandt%2C%20R.%20L.%2C%20Ayers%2C%20G.%20D.%2C%20%26amp%3B%20Richmond%2C%20A.%20%282021%29.%20Novel%20induction%20of%20CD40%20expression%20by%20tumor%20cells%20with%20RAS%5C%2FRAF%5C%2FPI3K%20pathway%20inhibition%20augments%20response%20to%20checkpoint%20blockade.%20%3Ci%3EMolecular%20Cancer%3C%5C%2Fi%3E%2C%20%3Ci%3E20%3C%5C%2Fi%3E%281%29%2C%2085.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12943-021-01366-y%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12943-021-01366-y%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D7753456%26amp%3Bitem_key%3DTKU98BGT%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Novel%20induction%20of%20CD40%20expression%20by%20tumor%20cells%20with%20RAS%5C%2FRAF%5C%2FPI3K%20pathway%20inhibition%20augments%20response%20to%20checkpoint%20blockade%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chi%22%2C%22lastName%22%3A%22Yan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nabil%22%2C%22lastName%22%3A%22Saleh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinming%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%20A.%22%2C%22lastName%22%3A%22Nebhan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20E.%22%2C%22lastName%22%3A%22Vilgelm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Premkumar%22%2C%22lastName%22%3A%22Reddy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20T.%22%2C%22lastName%22%3A%22Roland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%20B.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheau-Chiann%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebecca%20L.%22%2C%22lastName%22%3A%22Shattuck-Brandt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20D.%22%2C%22lastName%22%3A%22Ayers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ann%22%2C%22lastName%22%3A%22Richmond%22%7D%5D%2C%22abstractNote%22%3A%22While%20immune%20checkpoint%20blockade%20%28ICB%29%20is%20the%20current%20first-line%20treatment%20for%20metastatic%20melanoma%2C%20it%20is%20effective%20for%20~%5Cu200952%25%20of%20patients%20and%20has%20dangerous%20side%20effects.%20The%20objective%20here%20was%20to%20identify%20the%20feasibility%20and%20mechanism%20of%20RAS%5C%2FRAF%5C%2FPI3K%20pathway%20inhibition%20in%20melanoma%20to%20sensitize%20tumors%20to%20ICB%20therapy.%22%2C%22date%22%3A%22June%206%2C%202021%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12943-021-01366-y%22%2C%22ISSN%22%3A%221476-4598%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12943-021-01366-y%22%2C%22deleted%22%3A1%2C%22collections%22%3A%5B%22DUPVZUHA%22%5D%2C%22dateModified%22%3A%222021-06-09T15%3A37%3A32Z%22%7D%7D%5D%7D
Yan, C., Saleh, N., Yang, J., Nebhan, C. A., Vilgelm, A. E., Reddy, E. P., Roland, J. T., Johnson, D. B., Chen, S.-C., Shattuck-Brandt, R. L., Ayers, G. D., & Richmond, A. (2021). Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade. Molecular Cancer, 20(1), 85. https://doi.org/10.1186/s12943-021-01366-y Cite
